Indian variant could spread like wildfire as parts of Scotland look set to lift restrictions
Glasgow and Moray have both seen rises in coronavirus cases over the last couple of weeks.
10:51, 16 MAY 2021
The video will auto-play soon8Cancel
Play now
Join thousands of others and get the latest Scottish politics news sent straight to your inbox.Invalid EmailSomething went wrong, please try again later.
Subscribe
When you subscribe we will use the information you provide to send you these newsletters. Your information will be used in accordance with ourPrivacy Notice.
Thank you for subscribingWe have more newslettersShow meSee ourprivacy notice
LONDONÂ and NEW YORK
 , May 12, 2021 /PRNewswire/  Huma Therapeutics Limited today announces the completion of its latest funding round with financing of approximately $130 million. The investment will scale Huma s modular platform which can power digital hospitals at home nationally, and support the pharmaceutical and research industries to run the largest ever decentralized clinical trials. Huma s platform combines predictive algorithms, digital biomarkers and real-world data to advance proactive care and research.
Leaps by Bayer and Hitachi Ventures led the Series C funding round, which also saw new strategic and financial investors become shareholders. Samsung Next, Sony Innovation Fund by IGV , Unilever Ventures and HAT Technology & Innovation Fund by HAT, as well as individuals Nikesh Arora (former president of SoftBank) and Michael Diekmann (Chairman of Allianz) are also new shareholders.
Huma raises $130 million to finance its digital health platform
5 hours ago
Huma Therapeutics Limited thas raised approximately $130 million to scale its modular platform which can power digital ‘hospitals at home’ nationally, and support the pharmaceutical and research industries to run the largest ever decentralised clinical trials. Huma’s platform combines predictive algorithms, digital biomarkers and real-world data to advance proactive care and research.
Leaps by Bayer and Hitachi Ventures led the Series C funding round, which also saw new strategic and financial investors become shareholders. Samsung Next, Sony Innovation Fund by IGV, Unilever Ventures and HAT Technology & Innovation Fund by HAT, as well as individuals Nikesh Arora (former president of SoftBank) and Michael Diekmann (Chairman of Allianz) are also new shareholders.
Oxygen: 3 ప్లాంట్లతో అతిపెద్ద కార్గో విమానం భారత్కు eenadu.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eenadu.net Daily Mail and Mail on Sunday newspapers.
Laura Donnelly and Lizzie Roberts20:02, Apr 29 2021
Frank Augstein/AP
Britain s Prime Minister Boris Johnson gives a thumbs up after receiving the first dose of the AstraZeneca vaccine back in March.
Seven in 10 British adults now have antibodies against Covid-19 in a leap towards herd immunity that far exceeds government projections. The latest figures from the Office for National Statistics (ONS) in the UK show that 68 per cent of adults now have some level of protection against the virus, either from vaccination or prior infection. The level has risen by one-third in a month while infections have waned, meaning much of the upswing can be credited to Britain’s vaccine rollout.